Saint Louis University School of Medicine, Saint Louis, MO, USA.
Department of Orthopedic Surgery, Division of Sports Medicine and Shoulder Surgery, Saint Louis University School of Medicine, Saint Louis, MO, USA.
Phys Sportsmed. 2024 Jun;52(3):283-290. doi: 10.1080/00913847.2023.2246177. Epub 2023 Aug 12.
To evaluate the efficacy of post-operative gabapentin administration as an analgesic agent and its effect on narcotic use after orthopedic surgery in an outpatient sports medicine practice by comparing patients prior to and after initiating the routine use of gabapentin as part of a standardized post-operative pain medication regimen. We hypothesized that adding gabapentin to a multimodal post-operative pain regimen would decrease the number of requested pain medication refills and have no detrimental effect on Visual Analogue Scale and Single Assessment Numerical Evaluation scores at these early post-operative visits.
All outpatient surgical patients, <90 years of age, undergoing outpatient orthopedic surgery by the study's senior author were included between 08/05/2021 and 02/22/2022. Patients were allowed 1 narcotic refill post-operatively and only in the first 3 weeks. The primary outcome was difference in percentage of patients who requested a narcotic refill within 3 weeks post-op. Two- and 6-week Visual Analogue Scale and Single Assessment Numerical Evaluation scores, and baseline health and demographic data. T-tests were run on continuous variables, Chi-Square or Fisher's Exact Test were run on dichotomous variables, and Mann-Whitney U test was run on all other categorical variables. Statistical significance was set at < .05 for all tests.
There was a significant difference in narcotic refills at 3 weeks: 23 pre-gabapentin patients and 9 post-gabapentin patients (22.8% vs 9.0%, respectively: = .006). There were no differences between 2- and 6-week Visual Analogue Scale and 2-week Single Assessment Numerical Evaluation scores. There was a significant difference in 6-week SANE between groups: mean difference = 6.4 ( = .027) though less than the established MCID.
Addition of gabapentin to a post-operative multimodal pain regimen reduced the use of narcotics after orthopedic sports medicine surgeries while also providing equivalent pain control.
通过比较在开始常规使用加巴喷丁作为标准化术后疼痛管理方案的一部分之前和之后的患者,评估术后给予加巴喷丁作为镇痛剂在门诊运动医学实践中的疗效及其对骨科手术后阿片类药物使用的影响。我们假设将加巴喷丁加入多模式术后疼痛管理方案中会减少要求的止痛药物补充次数,并且在这些早期术后就诊时对视觉模拟量表和单一评估数字评估评分没有不利影响。
所有接受研究资深作者进行的门诊骨科手术的、年龄<90 岁的门诊手术患者均于 2021 年 8 月 5 日至 2022 年 2 月 22 日期间纳入研究。患者术后可要求补充 1 次阿片类药物,且仅在术后的前 3 周内。主要结局是术后 3 周内要求补充阿片类药物的患者百分比差异。还评估了术后 2 周和 6 周的视觉模拟量表和单一评估数字评估评分,以及基线健康和人口统计学数据。对连续变量进行 t 检验,对二分类变量进行卡方检验或 Fisher 精确检验,对所有其他分类变量进行 Mann-Whitney U 检验。所有检验的统计学显著性水平均设定为 < .05。
术后 3 周时,阿片类药物的补充有显著差异:23 例加巴喷丁治疗前患者和 9 例加巴喷丁治疗后患者(分别为 22.8%和 9.0%: = .006)。2 周和 6 周视觉模拟量表和 2 周单一评估数字评估评分无差异。组间 6 周 SANE 有显著差异:平均差异 = 6.4( = .027),尽管低于既定的 MCID。
在骨科运动医学手术后,将加巴喷丁加入术后多模式疼痛管理方案中可减少阿片类药物的使用,同时提供等效的疼痛控制。